PTC Therapeutics (PTCT) Q1 2024 Earnings
PTCT·Reported April 25, 2024·After market close
PTC Therapeutics reported Q1 2024 revenue of $210.1M, beat analyst consensus of $170.4M by $39.7M. Diluted EPS came in at $-1.20, beat the $-1.21 consensus by $0.01.
Revenue
$210.1Mbeat by $39.7M
Consensus: $170.4MDiluted EPS
$-1.20beat by $0.01
Consensus: $-1.21
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about PTC Therapeutics's Q1 2024 earnings report.
PTC Therapeutics (PTCT) reported Q1 2024 earnings on April 25, 2024 after market close.
PTC Therapeutics reported revenue of $210.1M and diluted EPS of $-1.20 for Q1 2024.
Revenue beat the consensus estimate of $170.4M by $39.7M. EPS beat the consensus estimate of $-1.21 by $0.01.
You can read the 10-Q periodic report (0001558370-24-005782) directly on SEC EDGAR. The filing index links above go to sec.gov.